TALOXA susp 600mg/5ml 230 ml
7680526790284
CH-52679
N03AX10
01.07.1.
Reimbursement limitations:
TALOXA2
Traitement adjuvant du syndrome de Lennox-Gastaut chez l'adulte et l'enfant de plus de 4 ans, …
1 / 3
google
Details
- Product number
- 5267901
- CPT
- -
- Packaging group
- 230
- Unit
- ml
- Composition
- felbamatum 600 mg, arom.: vanillinum et alia, saccharinum natricum, conserv.: E 211, propylis parahydroxybenzoas, E 218, excipiens ad suspensionem pro 5 ml.
Articles (1)
Taloxa, Suspension zum Einnehmen
suspension
230
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
Reimbursement information
Public price
CHF 118.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1998
Authorization holder
Organon GmbH
6006 Luzern
Authorization information
- Swissmedic authorization number
- 52679
- Drug name
- Taloxa, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- N03AX10
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/02/1997
- Authorization expiration date
- 31/12/9999
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TALOXA susp 600mg/5ml 230 ml
- Description (DE)
- TALOXA Susp 600mg/5ml 230 ml
- Market launch
- 25/02/1997
- Narcotic (BTM)
- No